Assembly Biosciences, Inc.
Hepatitis B core protein modulators
Last updated:
Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
Status:
Grant
Type:
Utility
Filling date:
30 May 2019
Issue date:
6 Apr 2021